PNPLA3 and metabolic syndrome: On the other hand, it may affect patients without the metabolic syndrome phenotype, but with genetic predisposition, where liver steatosis is due to genetic impairment of lipolysis, such as in the presence of genetic variation of PNPLA3 gene.